Drug Shortage Report for TEVA-SPIRONOLACTONE

Last updated on 2018-05-30 History
Report ID 42604
Drug Identification Number 00613215
Brand name TEVA-SPIRONOLACTONE
Common or Proper name SPIRONOLACTONE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) SPIRONOLACTONE
Strength(s) 25MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 UD
ATC code C03DA
ATC description POTASSIUM-SPARING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-03-07
Estimated end date 2018-04-15
Actual end date 2018-04-30
Shortage status Resolved
Updated date 2018-05-30
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-05-30 French Compare
v3 2018-05-30 English Compare
v2 2018-03-13 French Compare
v1 2018-03-13 English Compare